The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8575145, 67 ID: ALA3660063
PubChem CID: 67230791
Max Phase: Preclinical
Molecular Formula: C22H23N5O
Molecular Weight: 373.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1
Standard InChI: InChI=1S/C22H23N5O/c1-22(10-12-23-13-11-22)15-28-18-6-4-5-16-8-9-17(24-20(16)18)21-26-25-19-7-2-3-14-27(19)21/h2-9,14,23H,10-13,15H2,1H3
Standard InChI Key: LIKKMSJYXQMOCX-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
6.2385 -0.8914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2003 -1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -5.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0843 -6.1089 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5458 -7.5361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0450 -7.5380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0471 -8.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5147 -8.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9803 -6.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9782 -5.8023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5105 -6.1121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9026 -2.2040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9055 -3.7040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2059 -4.4515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5036 -3.6990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5007 -2.1990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 5 1 0
14 9 1 0
12 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 15 1 0
23 18 1 0
2 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 2 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.46Molecular Weight (Monoisotopic): 373.1903AlogP: 3.71#Rotatable Bonds: 4Polar Surface Area: 64.34Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.32CX LogP: 2.69CX LogD: -0.06Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -1.04
References 1. (2013) Triazolopyridine compounds as PIM kinase inhibitors,